CVKD - Company ID 0001937993
Cadrenal Therapeutics, Inc. trades as CVKD. This page tracks Cadrenal Therapeutics, Inc. through 237 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-11 |
| Major company event | 8-K | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-04-30 |
| EFFECT | - | 2026-04-29 |
| 424B3 | - | 2026-04-29 |
| Company correspondence | CORRESP | 2026-04-27 |
The largest companies sharing Cadrenal Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Cadrenal Therapeutics, Inc. reported a net loss of $13.24M.